Bausch Health director awarded 45,871 RSUs

Garcia Christian A reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

Garcia Christian A reported acquisition or exercise transactions in this Form 4 filing.

Bausch Health Companies Inc. director Christian A. Garcia received an award of 45,871 common shares on May 22, 2026, reported as restricted share units granted to non-employee directors. The RSUs have a grant-date value of $250,000 and vest immediately before the company’s next Annual Meeting of Shareholders.

After this equity award, Garcia directly holds 135,578 common shares. The RSUs will be settled in Bausch Health common shares when they vest, increasing his share ownership if he continues to serve through the vesting date.

Insider Trade Summary

Grant/Award: 45,871 shares

Grant/Award 1 txn

Insider Garcia Christian A

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Shares, No Par Value	45,871	$0.00	$0.00

Holdings After Transaction: Common Shares, No Par Value — 135,578 shares (Direct)

Footnotes (1)

1. F1. Represents the award of restricted share units ("RSUs") granted to non-employee directors of the Issuer on the third business day following their election at the Issuer's Annual Meeting of Shareholders. The RSUs have a grant date value of $250,000, vest on the date immediately preceding the Issuer's next Annual Meeting of Shareholders, and are settled in common shares, no par value, of the Issuer.

Key Figures

RSU grant size: 45,871 shares Grant-date value: $250,000 Post-grant holdings: 135,578 shares +2 more

5 metrics

RSU grant size 45,871 shares Restricted share units granted to non-employee director

Grant-date value $250,000 Value of RSUs granted to director

Post-grant holdings 135,578 shares Total common shares held directly after transaction

Transaction price $0.00 per share Equity grant, no cash paid by reporting person

Vesting timing Before next Annual Meeting RSUs vest immediately preceding next Annual Meeting of Shareholders

Key Terms

restricted share units ("RSUs"), non-employee directors, Annual Meeting of Shareholders, grant date value

4 terms

restricted share units ("RSUs") financial

"Represents the award of restricted share units ("RSUs") granted to non-employee directors"

non-employee directors financial

"RSUs granted to non-employee directors of the Issuer on the third business day"

Non-employee directors are board members who do not work for the company as salaried employees and usually do not hold day-to-day management roles. They act like outside referees or independent coaches, providing oversight, asking tough questions, and protecting shareholders’ interests; investors care because these directors help ensure management is accountable, reduce conflicts of interest, and influence decisions that affect company strategy and long-term value.

Annual Meeting of Shareholders financial

"granted to non-employee directors of the Issuer on the third business day following their election at the Issuer's Annual Meeting of Shareholders"

A yearly gathering where a company’s owners (shareholders) vote on key items like electing the board, approving executive pay, and ratifying auditors, and receive updates on performance and strategy. Think of it as an annual town hall for owners: it matters to investors because outcomes and disclosures can affect leadership, corporate direction, dividend and governance policies, and therefore the company’s risk and potential return.

grant date value financial

"The RSUs have a grant date value of $250,000, vest on the date immediately"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Bausch Health (BHC) director Christian A. Garcia report on this Form 4?

Christian A. Garcia reported receiving an equity award of 45,871 Bausch Health common shares in the form of restricted share units. These RSUs were granted as compensation for his role as a non-employee director and will vest before the next Annual Meeting of Shareholders.

How large is Christian A. Garcia’s new Bausch Health (BHC) RSU grant?

The new grant consists of 45,871 restricted share units with a grant-date value of $250,000. Each RSU represents one common share of Bausch Health, giving Garcia a significant stock-based component to his director compensation that aligns his interests with other shareholders.

When do Christian A. Garcia’s Bausch Health (BHC) RSUs vest?

The RSUs vest on the date immediately preceding Bausch Health’s next Annual Meeting of Shareholders. Vesting requires continued board service through that date, after which the RSUs will be settled in common shares, adding to Garcia’s directly held Bausch Health share position.

How many Bausch Health (BHC) shares does Christian A. Garcia hold after this Form 4 transaction?

Following the reported award, Garcia directly holds 135,578 Bausch Health common shares. This total reflects the addition of the 45,871-share RSU grant reported in the filing, which will be settled in common shares when the RSUs vest before the next Annual Meeting.

Was Christian A. Garcia’s Bausch Health (BHC) share award an open-market purchase?

No, the filing classifies the transaction under code “A” as a grant, award, or other acquisition, not an open-market purchase. The 45,871 RSUs were granted as director compensation at no cash cost per share, with a stated grant-date value of $250,000.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 05/26/2026 - 06:10 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Garcia Christian A

(Last) (First) (Middle)

400 SOMERSET CORPORATE BLVD.

(Street)

BRIDGEWATER NEW JERSEY 08807

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Bausch Health Companies Inc. [ BHC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/22/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Shares, No Par Value	05/22/2026		A		45,871(1)	A	$0	135,578	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents the award of restricted share units ("RSUs") granted to non-employee directors of the Issuer on the third business day following their election at the Issuer's Annual Meeting of Shareholders. The RSUs have a grant date value of $250,000, vest on the date immediately preceding the Issuer's next Annual Meeting of Shareholders, and are settled in common shares, no par value, of the Issuer.

	/s/ Brianna M. Dorsi, attorney-in-fact	05/26/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)